RGN Insider Trading Activity and SEC Form 4 Filings
RGN insider trading summary
No open-market insider purchases or sales of Regenerx Biopharmaceuticals Inc (RGN) have been reported on SEC Form 4 in the past 12 months.
Latest RGN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 11, 2010 | C Neil Lyons | CFO & Treasurer | Buy | $4K (15,000 @ $0.28) |
| Jun 10, 2010 | C Neil Lyons | CFO & Treasurer | Buy | $1K (5,000 @ $0.28) |
| May 21, 2010 | Paolo Cavazza | 10% Owner | Buy | $0 (240,000 @ $0.00) |
| Oct 8, 2009 | Consultadoria & Servicos SDC Unipessoal LDA Chaumiere | 10% Owner | Buy | $1000K (1,219,512 @ $0.82) |
| Oct 8, 2009 | Paolo Cavazza | 10% Owner | Buy | $1000K (1,219,512 @ $0.82) |
| Jun 2, 2009 | Consultadoria & Servicos L.D.A. Inverlochy | 10% Owner | Buy | $125K (312,500 @ $0.40) |
| Jun 2, 2009 | Consultadoria & Servicos SDC Unipessoal LDA Chaumiere | 10% Owner | Buy | $125K (312,500 @ $0.40) |
| Jun 2, 2009 | Richard J Hindin | Director | Sell | $250K (625,000 @ $0.40) |
| Jun 2, 2009 | Claudio Cavazza | 10% Owner | Buy | $125K (312,500 @ $0.40) |
| Jun 2, 2009 | Paolo Cavazza | 10% Owner | Buy | $125K (312,500 @ $0.40) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.